CollPlant Biotechnologies (CLGN) EBT Margin Growth (3y) (2020 - 2025)
CollPlant Biotechnologies (CLGN) EBT Margin Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 49,756.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 441.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 281,207.00 |
| Sep 30, 2025 | -45,546.00 |
| Jun 30, 2025 | 811,633.00 |
| Dec 31, 2024 | -119,607.00 |
| Sep 30, 2024 | -25.21 Mn |
| Jun 30, 2024 | 219,394.00 |
| Mar 31, 2024 | 434,773.00 |
| Dec 31, 2023 | -147,268.00 |
| Sep 30, 2023 | -67.50 Mn |
| Jun 30, 2023 | 28,478.00 |
| Mar 31, 2023 | 108,955.00 |
| Dec 31, 2022 | -641,104.00 |
| Sep 30, 2022 | -404,665.00 |
| Jun 30, 2022 | -673,645.00 |
| Dec 31, 2021 | -116,168.00 |
| Sep 30, 2021 | 13.79 Mn |
| Jun 30, 2021 | -102,611.00 |
| Mar 31, 2021 | -75,527.00 |
| Dec 31, 2020 | -87,139.00 |